{"name":"Immunis, Inc.","slug":"immunis-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNVDRGaU1UMlF4ank3dDFVVHVPV3VneTNFZk5zMVRiWjVQX0RrNTdNNTBqcUtlYnJEZ3BlaHlYeFZraVMydjA4WXV3YTZ1S2RNSHdMOExyQWd4NmVkcnNmd3hpblA1MGJ5Unk5akx4WXpiY0w4TnRtZzg0TWpmNDlTS19OY3BwYmVQZHBYVUJtam02Z3BIZ240SmRzVTNZSHlXYXBCSHhYUnB2d3ZVNDNSX1hvWHJ0V1BEellvOGxEYmt6bTZGVDUzY1Awc1NrOFVOWEZnRTIxMEtGeVE?oc=5","date":"2026-03-05","type":"deal","source":"Business Wire","summary":"Immunis Licenses Treatment Candidate for Dyskinesia Associated with Parkinson’s Disease - Business Wire","headline":"Immunis Licenses Treatment Candidate for Dyskinesia Associated with Parkinson’s Disease","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-14","type":"trial","source":"Business Wire","summary":"Immunis Announces Preliminary Results from First-Ever Phase 2 Study of a Secretome-Based Biologic Showing Weight Loss with Preserved Muscle and Improved Gait Speed in Obese Sarcopenic Seniors - Busine","headline":"Immunis Announces Preliminary Results from First-Ever Phase 2 Study of a Secretome-Based Biologic Showing Weight Loss wi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNOEVzbDliaWgyT0tLb1ZWQzlTRzV1dlI5WmZTYjZKRVhKREZCM25fNGh1LWM4UXFJa1NHcVY4VFd3cms5b1B3WUtPSWJHU2hXNUo2ejlwVG5FVWRnNUtmOUtBOUc1SjBfdlh3Wl9FUTFPQ3JVdExVcUZ4a183Wm5yYmhDNnJlRVNSVGZZbm8xbE9FX0lNNzNPV3VZUUdnaS1ydmdUWEQ5SjhINm42cmhFQVJQMUNGa1EtVW8wOW9nenlUVWZwa2ItNVVoOHN0d1F3QnpRYU1NeWU5MXE4cW5jNGRUWi1xYjVyUjlVLUw3ZWw3UnViTnhBWXl2WQ?oc=5","date":"2025-11-21","type":"pipeline","source":"Business Wire","summary":"Immunis Named by The Healthcare Technology Report as One of the “Top 50 Healthcare Technology Companies of 2025” - Business Wire","headline":"Immunis Named by The Healthcare Technology Report as One of the “Top 50 Healthcare Technology Companies of 2025”","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxONk5qaFpDcnBKejdKSmxqMDFHVUh0c05sdThsbVc1ZThVMTQ0c0Fhci1zMS1WdnFjODFybUFzblFvYjgzQU9WZUtGa1JUMl8xdU0wUGdVSEJFXzhaRWNqU240aHVNTUV6eTlGVU8tSnAxcmswNnpnMUpaR2J1LWFKeGlmREV3TXVNaFlmR19fMEU0UXRNemNhY2E0QUs5c1Z4M1JtbzdQdmF3Q0VrbURzeEtoOWV3ZWtKR0llWlZ4U2RGTVY1WkZERF8xR2Y3VlE1UGNaSFI4cEk4Q0ZncGl3bW1pXzlwQnZlazVnVHlkRm0xZw?oc=5","date":"2025-08-14","type":"pipeline","source":"Business Wire","summary":"Immunis Named Among Top 25 Biotech & Life Sciences Companies for 2025 by The Healthcare Technology Report - Business Wire","headline":"Immunis Named Among Top 25 Biotech & Life Sciences Companies for 2025 by The Healthcare Technology Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOU1JOTV9fRk80U3dfQUdRRF9nb1lvTzdaMWRXaE9FOFExbnUxYXFXc01rblg3QUVvbXI5RlpSR2RTYXpsb0t2WlpBVE9PSFpEOUtrWHFxcmRpQXZncElacHd2bXNHZkkyeVVNVE5nU2JfM3FyUEVKYXFwd1I0VTBxeGd6Q0VmR1RtUGIyNkQ4a2FrdThOdG9ZVmY3bmhwUQ?oc=5","date":"2025-08-12","type":"pipeline","source":"The Healthcare Technology Report.","summary":"The Top 25 Biotech and Life Sciences Companies of 2025 - The Healthcare Technology Report.","headline":"The Top 25 Biotech and Life Sciences Companies of 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOd282cEI0VzAyRGpOcFdqUWRHQ25id3kzMEVKX19vV285WTNvN0RiTlk5NkhMcHZrdnhlN3ZqNng0UmlRZ0l6Vjd2blF0cFJPXzBaSkk0UURBWHYwRDY0U0djRlA3UDVESlpkZk5JT0htbWhKZ1RwbDJ1VFZORWwxQw?oc=5","date":"2025-06-22","type":"pipeline","source":"Dermatology Times","summary":"Top 5 Articles of the Week: June 15-20 - Dermatology Times","headline":"Top 5 Articles of the Week: June 15-20","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQZEhBb0ZwWElqM2RrNHMxdEJBLW5WUWtydnFlV1BoeE9HSVhHMVByWlg5MXk1NTlkVzJ2aDdYRHo4WHhlOVpmeGd4SmRQbWF5X2dlblVVeDQ1cWdlRFVPQ3ByaGw1STJJdHU0eUlZMzdkcFdLaHBFeHBrY2E2ODJUbm5VTlhmUl9uaEgteXh5TG5aam1lSmZGQ2E5Q0xkWk9WVGU1SDUtM3EtRk9COGFF?oc=5","date":"2024-07-25","type":"deal","source":"Imaging Technology News","summary":"Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology - Imaging Technology News","headline":"Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQOWIwakZELWxZV0NTcVZIYWh2MVFNS2xpYWQ5UzMzODE5ZVpFZVlVVklIZFNlekh0Z0M3VU01Y1VnamliN01CY29zOG5wS25Ma0dCRWJIR09Bb1BOVFJCN0U2ak9vdnhXb2dycmFSa0F1TEhsTklDQVdyNTljSlItVkVOaS1uaXQwTm1WX2loSDBNaUdPTERzdUhVV3BvaUdMeUthTTVFSXhqVHBKS2p4VW5MODN3SmFoRWFhSjUwZWxYMVZFZ3l3Tm4wLW5PZDB5c3VmVGtoZERFb1dOcUQzbkNZaDg5Qi1ocElYSkkyamhTdGcyQ1E?oc=5","date":"2022-12-22","type":"pipeline","source":"Business Wire","summary":"Immunis Announces First-in-Human Injection of Secretome Product for Age and Disease-Related Immune Decline - Business Wire","headline":"Immunis Announces First-in-Human Injection of Secretome Product for Age and Disease-Related Immune Decline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE8ySTMyNEp0dk9HZTZFdXFrVFVMSk5xaTNjYnd0Z0VTM3FlNDRlNWRvTjdINGVhTGg0c1JEM2ZPc0JhUldEbmczdTRPdDNmN05VUDFaNUlTaUw1UG8wQ0ZobndoVmdTbjJpRGUyRmxoUlJnTU4zYUNlcThR?oc=5","date":"2022-08-04","type":"pipeline","source":"Labiotech.eu","summary":"Immunis closes $10M financing round - Labiotech.eu","headline":"Immunis closes $10M financing round","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}